Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy.
about
Imaging in breast cancer: Magnetic resonance spectroscopyEvaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancerMagnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatmentDynamic properties of water in breast pathology depend on the histological compounds: distinguishing tissue malignancy by water diffusion coefficientsVolume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer.Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopyComparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms.Two-dimensional MR spectroscopic characterization of breast cancer in vivo.Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T.Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS)Chemical shift-based water/fat separation: a comparison of signal models.Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.Magnetic resonance in the detection of breast cancers of different histological types.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerMRI in breast cancer therapy monitoringIn vivo 1H MRS in the assessment of the therapeutic response of breast cancer patientsIn vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.In vivo determination of human breast fat composition by ¹H magnetic resonance spectroscopy at 7 T.In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literatureTherapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Choline metabolism in cancer: implications for diagnosis and therapy.Near-infrared optical mammography for breast cancer detection with intrinsic contrast.Metabolite quantification and high-field MRS in breast cancerUtilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy.Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy.Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.Can Multi-Parametric MR Based Approach Improve the Predictive Value of Pathological and Clinical Therapeutic Response in Breast Cancer Patients?
P2860
Q24810795-66B5DFDB-3C67-43F4-9E83-4DC7CA354A3DQ28362929-C751F26A-0A4A-4C74-9318-E345BD50AAA2Q28477468-6BDC708E-E86A-4633-ABFE-59AE8ED0F14CQ30420673-7DB2AE45-A9CD-43B3-8438-9C7BB5B370C5Q30657513-DFCA16B2-9125-43C4-82DC-5AB1EEC77B5EQ30682911-1C1DB047-22A7-48F9-88EA-8FFC472D0B80Q30884828-2094E672-7E27-4AF6-95BE-BDA020D9EAF6Q30980322-B8CEA61A-AC74-476A-B343-04C5FE46478CQ31032006-E701E02C-D4F2-4234-8907-53943B06A652Q31138977-369C5178-4FF2-4D91-AA36-D4962C77F883Q33517556-8BFB4DE4-2E0C-40EE-A475-14790F591031Q33552272-ADA6F4F3-8531-43BD-9522-D9B2041E11D4Q33622591-93EB2738-8B41-4C3A-964D-0FAD509F2187Q33705690-A7FE7DEE-0D0A-4148-B9D5-FB5F1B3F4519Q33857530-7CD9B3F0-E12B-4F6C-8463-83FDCA9CC9CAQ33873362-2CA7A320-7E08-4284-B7DF-7A801BF984D5Q33881902-AC51409B-5BBE-4D5F-97E0-3BA45ADB9E42Q33938324-0A1AA5EC-BB83-44CF-AD8B-1BD1DAF2942AQ33972737-9B4FEB91-5718-40D3-87B3-6FF85DADDC8AQ34016780-15F72946-4577-4D2A-98CF-E8E9566992AEQ34035237-D99D6C0F-2917-45A7-A489-7275CE277BB4Q34050338-AD8C1D47-0351-46C8-8065-6B0930A0DF9DQ35631709-48EA60CE-267F-47B9-BC41-0E187E9E8D5CQ36245493-5B943FF1-A00D-4E1A-9E5D-27CED36B4D54Q36630017-AAE9B494-738B-49AE-80A3-8EDC10EB0043Q36670926-9EEE08F2-1F88-4678-ABE5-C38A8DB868B6Q36918199-EEE1BC36-9D41-454F-954B-F78DD0CEA775Q36980478-283DE4D4-0D9C-4DDE-A949-F86CE09E210AQ38442666-33E9290B-54FC-47A3-9F09-CDDC83ACF93DQ45023411-8C4B7436-592F-404B-A2B2-E186B53A8552Q51458748-6AEA5523-6032-438D-B349-277F02320104Q58777270-31D96C03-5E36-47CE-AE6D-B3508277901F
P2860
Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Volume localized in vivo proto ...... tients receiving chemotherapy.
@ast
Volume localized in vivo proto ...... tients receiving chemotherapy.
@en
type
label
Volume localized in vivo proto ...... tients receiving chemotherapy.
@ast
Volume localized in vivo proto ...... tients receiving chemotherapy.
@en
prefLabel
Volume localized in vivo proto ...... tients receiving chemotherapy.
@ast
Volume localized in vivo proto ...... tients receiving chemotherapy.
@en
P2093
P2860
P1433
P1476
Volume localized in vivo proto ...... tients receiving chemotherapy.
@en
P2093
Govindaraju V
Jagannathan NR
Raghunathan P
P2860
P304
P356
10.1002/(SICI)1099-1492(199812)11:8<414::AID-NBM537>3.0.CO;2-W
P577
1998-11-01T00:00:00Z